According to the report titled ‘Global Vagus Nerve Stimulator Market Size study with COVID-19 Impact, by Type (Invasive, Non-Invasive), by Application (Epilepsy, Treatment Resistant Depression (TRD), Others), by End-Use (Hospitals, Speciality Clinics) and Regional Forecasts 2020-2027’, available with Market Study Report, global vagus nerve stimulator market was valued at USD 562.8 million in 2019 and is projected to record a CAGR of 11.4% during 2020-2027.
 

For those uninitiated, vagus nerve stimulator electronic device controls specific working and functions of the brain. It is implanted in patient’s body over vagus nerve, and provides electrical stimulation when necessary. The ability of stimulators to improve movements, control bladder difficulties, and help in restoring other neurological conditions like migraine, and headaches is propelling the growth of global vagus nerve stimulator market.
 

Further, the product is also beneficial for patients suffering from cardiovascular diseases, depression, and asthma. Its success rate in treating neurological disorders is one of the major factors impelling the vagus nerve stimulator industry expansion, alongside technological enhancements leading to introduction of compact devices.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2706254/
 

The outbreak of COVID-19 pandemic has a trivial impact on global vagus nerve stimulator market as essential services were given a higher priority amidst lockdowns in major economies globally. In addition, increasing prevalence of a common neurological condition, epilepsy in Brazil and China is further facilitating the business scenario. However, hefty cost of treatment is likely to hinder global vagus nerve stimulator industry forecasts.
 

Based on type, worldwide vagus nerve stimulator market is divided into non-invasive and invasive. Speaking of application spectrum, the industry is bifurcated into treatment resistant depression (TRD), epilepsy, and others. In terms of end-use scope, the market is split into specialty clinics and hospitals.
 

Citing regional landscape, worldwide vagus nerve stimulator market is segmented into Latin America, Europe, North America, Asia Pacific, and Rest of the World. The report claims that North America presently accounts for a considerable market share owing to incorporation of advanced technologies in healthcare sector.
 

Meanwhile, Asia Pacific vagus nerve stimulator industry is expected to register decent growth over the study period, on account of increasing instances of neurological disorders and favorable government initiatives for improving healthcare services.
 

Major contenders impacting global vagus nerve stimulator market dynamics are Beijing Pins Medical Co. Ltd., Cerbomed GmbH (acquired by tVNS Technologies GmbH), Inspire Medical Systems Inc., ImThera Medical Inc., NeuroMetrix Inc., Cyberonics Inc., Boston Scientific Corporation, electroCore Medical LLC, EnteroMedics Inc., and LivaNova PLC.